SCHEMBL1522428

SCHEMBL1522428

Cc1ccc2c(=O)oc(=O)n(Cc3ccccc3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.46
MIF P14174 3/20 0.46
CD74 P04233 1/20 0.46
HPGD P15428 5/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 3/20 0.45
HTT P42858 2/20 0.45
GAA P10253 1/20 0.45
TSHR P16473 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PSMD14 O00487 1/20 0.45
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RECQL P46063 1/20 0.45
RAB9A P51151 1/20 0.45
PKM P14618 1/20 0.42
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11495935 0.82 ADORA1 (0.50) ADORA1HPGDKDM4ELMNAHTT
SCHEMBL1523079 0.80 TSHR (0.46) MIFCD74HPGDLMNATSHR
SCHEMBL1522698 0.79 PTGDR2 (0.51) MIFKDM4EMEN1KMT2AALDH1A1
SCHEMBL5871423 0.74 KDM4E (0.58) ADORA1HPGDKDM4ELMNAHTT
SCHEMBL1523060 0.74 MIF (0.44) MIFCD74HPGDKDM4ELMNA
SCHEMBL1523149 0.73 MIF (0.53) MIFCD74KDM4ELMNATSHR
SCHEMBL1522607 0.73 MIF (0.66) MIFCD74KDM4EMEN1KMT2A
SCHEMBL1522225 0.73 PTGDR2 (0.55) HPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL1522725 0.73 MIF (0.41) MIFCD74HPGDKDM4ELMNA
SCHEMBL1522614 0.72 ALDH1A1 (0.57) MIFCD74HPGDLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361913-A1 Anti-infective agents Abbott Laboratories (US) 2011-08-31 EP disclosed
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB ADORA1 4282/4885MIF 1032/4885CD74 399/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB ADORA1 4282/4885MIF 1032/4885CD74 399/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 ADORA1 3326/4885MIF 188/4885CD74 384/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT ADORA1 4172/4885MIF 243/4885CD74 236/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB ADORA1 4282/4885MIF 1032/4885CD74 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.